Delivery Order SPE2DB20D3505-SPE2DB25FU7M1
Award Date
6/4/25
Potential Completion Date
6/5/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Candesartan Cilexetil 32 mg tablets, a medication used to treat high blood pressure and heart failure. The total ceiling value of the contract is $8,333.90, and it has a period of performance through December 17, 2024. The contract is a firm-fixed price delivery order and does not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,022.52 firm fixed-price contract is for the delivery of candesartan cilexetil 32 mg tablets, which are used to treat high blood pressure and heart failure. The contract has an ultimate completion date of August 12, 2022. The delivery order was issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Candesartan Cilexetil 32 mg tablets, a medication used to treat high blood pressure and heart failure. The contract has a firm fixed price of $17,955.15 and a completion date of May 23, 2025. There is no set-aside designation, indicating the contract was awarded through open competition. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Candesartan Cilexetil 16 mg tablets, a pharmaceutical product used in the treatment of hypertension and heart failure. The contract has a ceiling value of $11,747.16 and a period of performance through May 13, 2025. This contract is not designated as a set-aside and was awarded on...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Candesartan Cilexetil 8 mg tablets, a medication used for the treatment of hypertension and heart failure. The contract has a ceiling value of $3,340.44 and an ultimate completion date of March 12, 2025. It is a Firm Fixed Price contract, with no set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,213.13, is for the supply of 90 tablets of 8 mg Candesartan Cilexetil, a cardiovascular medication. The contract has a period of performance through February 28, 2025 and utilizes a firm fixed price pricing type. This order is part of a larger Indefinite Delivery...
This federal contract award, valued at $38,542.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets, which are used to treat high blood pressure and heart failure. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,832.28, is for the provision of Candesartan Cilexetil 32 mg tablets. The contract is a firm fixed-price delivery order with a period of performance through November 6, 2024. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,806.19 delivery order is for Candesartan Cilexetil 16 mg tablets, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of October 28, 2024 and utilizes a firm fixed-price pricing structure. This award is associated with a larger Indefinite Delivery...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,498.49, is for the delivery of 32 mg Candesartan Cilexetil tablets in 90-count bottles. The contract is a firm fixed-price delivery order with a completion date of March 13, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999...